Gunshin Hiromi, Fujiwara Yuko, Custodio Angel O, Direnzo Cristina, Robine Sylvie, Andrews Nancy C
Children's Hospital Boston, Dana-Farber Cancer Institute, Harvard Medical School, Massachusetts 02115, USA.
J Clin Invest. 2005 May;115(5):1258-66. doi: 10.1172/JCI24356. Epub 2005 Apr 21.
Solute carrier family 11, member 2 (SLC11A2) is the only transmembrane iron transporter known to be involved in cellular iron uptake. It is widely expressed and has been postulated to play important roles in intestinal iron absorption, erythroid iron utilization, hepatic iron accumulation, placental iron transfer, and other processes. Previous studies have suggested that other transporters might exist, but their physiological significance remained uncertain. To define the activities of Slc11a2 in vivo, we inactivated the murine gene that encodes it globally and selectively. We found that fetal Slc11a2 is not needed for materno-fetal iron transfer but that Slc11a2 activity is essential for intestinal non-heme iron absorption after birth. Slc11a2 is also required for normal hemoglobin production during the development of erythroid precursors. However, hepatocytes and most other cells must have an alternative, as-yet-unknown, iron uptake mechanism. We previously showed that Slc11a2 serves as the primary portal for intestinal iron entry in hemochromatosis. However, inactivation of murine Hfe ameliorates the phenotype of animals lacking Slc11a2.
溶质载体家族11成员2(SLC11A2)是已知参与细胞铁摄取的唯一跨膜铁转运蛋白。它广泛表达,并被推测在肠道铁吸收、红细胞铁利用、肝脏铁蓄积、胎盘铁转运及其他过程中发挥重要作用。以往研究提示可能存在其他转运蛋白,但其生理意义仍不明确。为了确定Slc11a2在体内的活性,我们使编码该蛋白的小鼠基因在整体和选择性条件下失活。我们发现胎儿期的Slc11a2并非母婴铁转运所必需,但Slc11a2活性对于出生后肠道非血红素铁的吸收至关重要。在红系前体细胞发育过程中,正常血红蛋白的产生也需要Slc11a2。然而,肝细胞和大多数其他细胞必定具有一种尚未明确的替代性铁摄取机制。我们之前表明,Slc11a2是血色素沉着症中肠道铁进入的主要通道。然而,小鼠Hfe的失活改善了缺乏Slc11a2的动物的表型。